Kerala govt decides to act against misuse of monoclonal antibody drug

The government decided to regulate the drug after it was found to be in use in many private hospitals in the state. 

published on : 9th February 2022

‘Covid antibody therapy is unethical and immoral’: Dr Gagandeep Kang

The government has also excluded monoclonal antibodies treatment for Covid in the revised National Covid task force treatment.

published on : 25th January 2022

Should you take the cocktail shot?

As the world stands divided on this, city doctors share if monoclonal antibody therapy is a viable solution

published on : 12th January 2022

COVID-19: Monoclonal antibody cocktail finds more takers in Kerala despite high price

Certain national and international research reports revealed that MAB doses are not approved for people who are hospitalised with severe COVID infection and those requiring oxygen.

published on : 3rd January 2022

Steady demand for antibody cocktail in Mysuru district

Doctors are recommending antibody cocktail to reverse Covid effects to those infected with SARS-CoV-2 having mild or moderate symptoms.

published on : 13th December 2021

Study suggests antibodies reduce after getting Covid, but not after vaccination

The daily rate of antibody decay post vaccination among those who took just one dose by round 3 is insignificant, the study said.

published on : 19th November 2021

Antibody injection cuts severe COVID-19 risk, concludes AstraZeneca study

TACKLE included 903 participants in a 1:1 randomisation AZD7442 to placebo and the primary analysis was based on 822 participants.

published on : 11th October 2021

Drugmaker AstraZeneca asks US FDA to authorize COVID antibody treatment

The treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention.

published on : 5th October 2021

Indian scientists crack dengue vaccination challenge

Scientists selected a part of an important viral protein from four different variations of the dengue virus to develop the vaccine candidate as a ‘consensus vaccine’ that could be effective.

published on : 4th October 2021

For Covid-cured, one dose of Covaxin is equivalent to two doses, says study

As a part of the study, blood samples were collected from 114 healthcare professionals and frontline workers who received Covaxin at vaccination centres in Chennai from February to May 2021.

published on : 28th August 2021

UK rolls out free home antibody tests under new programme for COVID positives

The UK Health Security Agency will offer these finger-prick tests to help improve the understanding of immunity against COVID-19 from vaccination and infection.

published on : 22nd August 2021

Hyderabad: Covid patients who took antibody cocktail show encouraging response

Nearly  60 patients who have received the much talked about Monoclonal Antibody Cocktail Therapy in Gandhi Hospital free-of-cost have shown an encouraging response against Covid-19.

published on : 10th August 2021

COVID-19: Antibody cocktail gaining traction due to better recovery in mild cases

More and more doctors advising therapy as it promises better recovery in mild Covid cases

published on : 4th August 2021

Antibody cocktail centres in Karnataka will blunt Covid third wave edge: Experts

According to Dr Gopikrishna, consultant physician, Sevakshetra Hospital, availability of this treatment at subsidised rates will definitely help those who cannot afford it.

published on : 4th August 2021